Great-West Lifeco Inc (TSE:GWO) Director Michel Plessis-Bélair bought 10,000 shares of the stock in a transaction dated Friday, March 20th. The stock was bought at an average cost of C$23.71 per share, with a total value of C$237,100.00. Following the purchase, the director now owns 50,000 shares in the company, valued at approximately C$1,185,500.

Michel Plessis-Bélair also recently made the following trade(s):

  • On Tuesday, March 24th, Michel Plessis-Bélair purchased 5,000 shares of Great-West Lifeco stock. The shares were acquired at an average cost of C$21.72 per share, with a total value of C$108,576.00.

GWO opened at C$23.61 on Thursday. The business has a 50 day simple moving average of C$30.23 and a two-hundred day simple moving average of C$31.91. The firm has a market capitalization of $20.44 billion and a price-to-earnings ratio of 9.47. The company has a debt-to-equity ratio of 27.24, a current ratio of 13.24 and a quick ratio of 10.90. Great-West Lifeco Inc has a one year low of C$18.88 and a one year high of C$35.60.

Great-West Lifeco (TSE:GWO) last released its quarterly earnings results on Wednesday, February 12th. The company reported C$0.80 EPS for the quarter, beating analysts’ consensus estimates of C$0.79 by C$0.01. The business had revenue of C$10.69 billion for the quarter. As a group, sell-side analysts expect that Great-West Lifeco Inc will post 3.3900001 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.438 per share. This is an increase from Great-West Lifeco’s previous quarterly dividend of $0.41. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $1.75 dividend on an annualized basis and a dividend yield of 7.42%. Great-West Lifeco’s dividend payout ratio is 66.27%.

A number of research analysts have commented on the company. CIBC upped their price target on Great-West Lifeco from C$34.00 to C$36.00 in a research report on Friday, February 14th. National Bank Financial lowered their price target on Great-West Lifeco from C$33.00 to C$31.00 in a research report on Monday, March 9th. Credit Suisse Group reaffirmed a “neutral” rating and set a C$37.00 price target on shares of Great-West Lifeco in a research report on Friday, February 7th. BMO Capital Markets upped their price target on Great-West Lifeco from C$34.00 to C$35.00 in a research report on Friday, February 14th. Finally, TD Securities raised Great-West Lifeco from a “hold” rating to a “buy” rating and lowered their price target for the company from C$35.00 to C$29.00 in a research report on Monday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of C$33.60.

Great-West Lifeco Company Profile

Great-West Lifeco Inc, a financial services holding company, engages in life and health insurance, asset management, investment and retirement savings, and reinsurance businesses in Canada, the United States, and Europe. The company offers a portfolio of financial and benefit plan solutions for individuals, families, businesses, and organizations; life, disability, critical illness, accidental death, dismemberment, dental protection, direct marketing, health, and creditor insurance products; and wealth savings and income, accumulation, and annuity products.

Featured Story: Moving Average (MA)

Receive News & Ratings for Great-West Lifeco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Great-West Lifeco and related companies with MarketBeat.com's FREE daily email newsletter.